
    
      This clinical investigation is an international, multi-center, randomized controlled trial
      with angiographic follow up at 6 months. Clinical follow ups will take place at 6, 12 and 18
      months.

      Up to 210 subjects will be block randomized 2:1 to receive the Pantera Lux balloon or the
      Orsiro stent and will be stratified according to diabetic status at screening.
    
  